Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

robot
Abstract generation in progress

Sarepta Therapeutics, Inc. announced that it granted equity awards consisting of 113,855 restricted stock units (RSUs) to 24 new employees hired in the first quarter of 2026. These awards were approved by the Compensation Committee and are considered a material inducement to employment, in accordance with Nasdaq Listing Rule 5635©(4). The RSUs will vest over four years, with one-fourth vesting each year, contingent on continued employment.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin